427 related articles for article (PubMed ID: 20638156)
1. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
[TBL] [Abstract][Full Text] [Related]
2. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
[TBL] [Abstract][Full Text] [Related]
3. Use of integrated FDG-PET/CT in sarcoidosis.
Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
[TBL] [Abstract][Full Text] [Related]
4. Muscular sarcoidosis detected by F-18 FDG PET/CT in a hypercalcemic patient.
Han EJ; Jang YS; Lee IS; Lee JM; Kang S; Kim HS
J Korean Med Sci; 2013 Sep; 28(9):1399-402. PubMed ID: 24015050
[TBL] [Abstract][Full Text] [Related]
5. Sarcoidosis mimicking metastatic gynaecological malignancies: a diagnostic and therapeutic challenge?
Mapelli P; Mangili G; Picchio M; Rabaiotti E; Gianolli L; Messa C; Candiani M
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):314-7. PubMed ID: 23270913
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
7. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
8. Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.
Li YJ; Zhang Y; Gao S; Bai RJ
Clin Nucl Med; 2007 Mar; 32(3):262-4. PubMed ID: 17314619
[No Abstract] [Full Text] [Related]
9. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
[TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab.
Miller CT; Sweiss NJ; Lu Y
Clin Nucl Med; 2016 May; 41(5):417-8. PubMed ID: 26828145
[TBL] [Abstract][Full Text] [Related]
11. Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis.
Ng D; Jacobs M; Mantil J
Clin Nucl Med; 2006 Jul; 31(7):373-5. PubMed ID: 16785800
[TBL] [Abstract][Full Text] [Related]
12. The Utility of
Chen H; Jin R; Wang Y; Li L; Li K; He Y
Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996
[TBL] [Abstract][Full Text] [Related]
13. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis.
Bolat S; Berding G; Dengler R; Stangel M; Trebst C
J Neurol Sci; 2009 Dec; 287(1-2):257-9. PubMed ID: 19755199
[TBL] [Abstract][Full Text] [Related]
14. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
15. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
[TBL] [Abstract][Full Text] [Related]
16. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
[TBL] [Abstract][Full Text] [Related]
17. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
[TBL] [Abstract][Full Text] [Related]
18. The possible role of F-18 FDG positron emission tomography in the differential diagnosis of focal pancreatic lesions.
Papós M; Takács T; Trón L; Farkas G; Ambrus E; Szakáll S; Lonovics J; Csernay L; Pávics L
Clin Nucl Med; 2002 Mar; 27(3):197-201. PubMed ID: 11852308
[TBL] [Abstract][Full Text] [Related]
19. Nonfunctioning endocrine pancreatic tumor examined with 18F-FDG PET/CT.
Toshikuni N; Kai K; Fujisawa M
Ann Nucl Med; 2008 Feb; 22(2):133-7. PubMed ID: 18311538
[TBL] [Abstract][Full Text] [Related]
20. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
